Literature DB >> 24757663

Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy.

An Na Seo1, Haeryoung Kim2.   

Abstract

Entities:  

Keywords:  Drug-induced liver injury; Pathology; Sinusoidal obstruction syndrome

Mesh：

Substances：

Year:  2014        PMID： 24757663      PMCID： PMC3992335          DOI： 10.3350/cmh.2014.20.1.81

Source DB:  PubMed          Journal:  Clin Mol Hepatol        ISSN： 2287-2728


× No keyword cloud information.
  12 in total

1.  Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

Authors:  Jean-Nicolas Vauthey; Timothy M Pawlik; Dario Ribero; Tsung-Teh Wu; Daria Zorzi; Paulo M Hoff; Henry Q Xiong; Cathy Eng; Gregory Y Lauwers; Mari Mino-Kenudson; Mauro Risio; Andrea Muratore; Lorenzo Capussotti; Steven A Curley; Eddie K Abdalla
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

2.  Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy.

Authors:  Paul Ryan; Sulaiman Nanji; Aaron Pollett; Malcolm Moore; Carol-Anne Moulton; Steven Gallinger; Maha Guindi
Journal:  Am J Surg Pathol       Date:  2010-06       Impact factor: 6.394

3.  Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.

Authors:  Michael J Overman; Dipen M Maru; Chusilp Charnsangavej; Evelyn M Loyer; Huamin Wang; Priyanka Pathak; Cathy Eng; Paulo M Hoff; Jean-Nicolas Vauthey; Robert A Wolff; Scott Kopetz
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

Review 4.  Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

Authors:  Laurie D DeLeve; Howard M Shulman; George B McDonald
Journal:  Semin Liver Dis       Date:  2002-02       Impact factor: 6.115

Review 5.  Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases.

Authors:  G Morris-Stiff; Y-M Tan; J N Vauthey
Journal:  Eur J Surg Oncol       Date:  2007-08-30       Impact factor: 4.424

6.  Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.

Authors:  Hiroshi Nakano; Elie Oussoultzoglou; Edoardo Rosso; Selenia Casnedi; Marie-Pierre Chenard-Neu; Patrick Dufour; Philippe Bachellier; Daniel Jaeck
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

7.  Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases.

Authors:  S Kandutsch; M Klinger; S Hacker; F Wrba; B Gruenberger; T Gruenberger
Journal:  Eur J Surg Oncol       Date:  2008-02-12       Impact factor: 4.424

8.  Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

Authors:  L Rubbia-Brandt; V Audard; P Sartoretti; A D Roth; C Brezault; M Le Charpentier; B Dousset; P Morel; O Soubrane; S Chaussade; G Mentha; B Terris
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

9.  Chemotherapy-associated hepatopathy in korean colorectal cancer liver metastasis patients: oxaliplatin-based chemotherapy and sinusoidal injury.

Authors:  Soo Jeong Nam; Jai Young Cho; Hye Seung Lee; Gheeyoung Choe; Ja June Jang; Yoo-Seok Yoon; Ho-Seong Han; Haeryoung Kim
Journal:  Korean J Pathol       Date:  2012-02-23

10.  Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.

Authors:  Bernard Nordlinger; Halfdan Sorbye; Bengt Glimelius; Graeme J Poston; Peter M Schlag; Philippe Rougier; Wolf O Bechstein; John N Primrose; Euan T Walpole; Meg Finch-Jones; Daniel Jaeck; Darius Mirza; Rowan W Parks; Laurence Collette; Michel Praet; Ullrich Bethe; Eric Van Cutsem; Werner Scheithauer; Thomas Gruenberger
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321
View more
  8 in total

Review 1.  [Management of intraoperative and postoperative bleeding in liver surgery].

Authors:  R Sucher; D Seehofer; J Pratschke
Journal:  Chirurg       Date:  2015-02       Impact factor: 0.955

2.  A Case Report of Nodular Regenerative Hyperplasia and Non-cirrhotic Portal Hypertension Post Oxaliplatin Chemotherapy.

Authors:  Nagapratap Ganta; Ankita Prasad; Mina Aknouk; Kajal Ghodasara; Ambica Nair; Zehra Taqvi; Pramil Cheriyath
Journal:  Cureus       Date:  2022-09-03

3.  Chemotherapy induced liver abnormalities: an imaging perspective.

Authors:  Ankush Sharma; Roozbeh Houshyar; Priya Bhosale; Joon-Il Choi; Rajesh Gulati; Chandana Lall
Journal:  Clin Mol Hepatol       Date:  2014-09

4.  Commitment of Scaffold Proteins in the Onco-Biology of Human Colorectal Cancer and Liver Metastases after Oxaliplatin-Based Chemotherapy.

Authors:  Deborah Rotoli; Manuel Morales; Julio Ávila; María Del Carmen Maeso; María Del Pino García; Ali Mobasheri; Pablo Martín-Vasallo
Journal:  Int J Mol Sci       Date:  2017-04-22       Impact factor: 5.923

5.  Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin-based chemotherapy.

Authors:  Shinichiro Kobayashi; Sadayuki Okudaira; Kazuma Kobayashi; Kengo Kanetaka; Susumu Eguchi
Journal:  Clin Case Rep       Date:  2019-01-09

Review 6.  Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System.

Authors:  Taurean Brown; DeLawrence Sykes; Antiño R Allen
Journal:  Biomedicines       Date:  2021-02-13

7.  Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective.

Authors:  Danny Ngo; Jemianne Bautista Jia; Christopher S Green; Anjalie T Gulati; Chandana Lall
Journal:  Insights Imaging       Date:  2015-10-06

8.  Blue Liver: Case Report of Blue Liver.

Authors:  Ghaith Al-Qudah; Maher Ghanem; John Blebea; Samuel Shaheen
Journal:  Am J Case Rep       Date:  2020-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.